Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Stevanato Group S.p.A. (STVN:NYSE), powered by AI.
Stevanato Group S.p.A. is currently trading at $16.51. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Stevanato Group S.p.A. on Alpha Lenz.
Stevanato Group S.p.A.'s P/E ratio is 32.2.
“Stevanato Group S.p.A. trades at a P/E of 32.2 (premium valuation) with solid ROE of 9.7%.”
Ask for details →Stevanato Group S.p.A. is a leading Italian manufacturer specializing in medical equipment, supplies, and distribution, with a strong global presence in the biopharmaceutical and diagnostic solutions sectors. The company is recognized for its extensive portfolio, which includes glass primary packaging and integrated solutions for the containment and delivery of injectable drugs, as well as engineering systems for pharmaceutical manufacturing. Stevanato Group’s operations play a critical role in the healthcare supply chain, supporting the safe and efficient delivery of advanced therapies and diagnostics. Leveraging a highly collaborative approach, the company establishes long-term strategic partnerships with major pharmaceutical and biotechnology firms, contributing to high customer retention and continuous innovation. With a rapidly expanding footprint and a focus on technology-driven solutions, Stevanato Group S.p.A. is positioned as a significant player in the advancement of healthcare infrastructure and delivery across major global markets.
“Stevanato Group S.p.A. trades at a P/E of 32.2 (premium valuation) with solid ROE of 9.7%.”
Ask for details →Stevanato Group S.p.A. (ticker: STVN) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 5,521 employees. Market cap is $4.5B.
The current price is $16.51 with a P/E ratio of 32.23x and P/B of 3.03x.
ROE is 9.67% and operating margin is 16.76%. Annual revenue is $1.2B.